Biotrend Cevre ve Enerji Yatirimlari A.S. (IST:BIOEN)

IST:BIOEN Statistics

Total Valuation

IST:BIOEN has a market cap or net worth of TRY 9.98 billion. The enterprise value is 14.96 billion.

Market Cap	9.98B
Enterprise Value	14.96B

Important Dates

The last earnings date was Friday, November 7, 2025.

Earnings Date	Nov 7, 2025
Ex-Dividend Date	n/a

Share Statistics

IST:BIOEN has 500.00 million shares outstanding.

Current Share Class	500.00M
Shares Outstanding	500.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	21.40%
Float	227.56M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.47
PB Ratio	2.29
P/TBV Ratio	2.62
P/FCF Ratio	9.52
P/OCF Ratio	6.76
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 53.86, with an EV/FCF ratio of 14.28.

EV / Earnings	-19.06
EV / Sales	6.70
EV / EBITDA	53.86
EV / EBIT	n/a
EV / FCF	14.28

Financial Position

The company has a current ratio of 0.46, with a Debt / Equity ratio of 1.16.

Current Ratio	0.46
Quick Ratio	0.15
Debt / Equity	1.16
Debt / EBITDA	15.46
Debt / FCF	4.83
Interest Coverage	-1.08

Financial Efficiency

Return on equity (ROE) is -18.87% and return on invested capital (ROIC) is -2.78%.

Return on Equity (ROE)	-18.87%
Return on Assets (ROA)	-2.56%
Return on Invested Capital (ROIC)	-2.78%
Return on Capital Employed (ROCE)	-4.63%
Revenue Per Employee	3.16M
Profits Per Employee	-1.11M
Employee Count	717
Asset Turnover	0.24
Inventory Turnover	6.28

Taxes

Income Tax	-47.20M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +16.74% in the last 52 weeks. The beta is 0.07, so IST:BIOEN's price volatility has been lower than the market average.

Beta (5Y)	0.07
52-Week Price Change	+16.74%
50-Day Moving Average	23.20
200-Day Moving Average	21.05
Relative Strength Index (RSI)	33.79
Average Volume (20 Days)	2,434,984

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, IST:BIOEN had revenue of TRY 2.23 billion and -784.72 million in losses. Loss per share was -1.57.

Revenue	2.23B
Gross Profit	76.17M
Operating Income	-385.19M
Pretax Income	-826.70M
Net Income	-784.72M
EBITDA	238.83M
EBIT	-385.19M
Loss Per Share	-1.57

Balance Sheet

The company has 82.29 million in cash and 5.06 billion in debt, giving a net cash position of -4.98 billion or -9.96 per share.

Cash & Cash Equivalents	82.29M
Total Debt	5.06B
Net Cash	-4.98B
Net Cash Per Share	-9.96
Equity (Book Value)	4.35B
Book Value Per Share	8.69
Working Capital	-1.15B

Cash Flow

In the last 12 months, operating cash flow was 1.48 billion and capital expenditures -427.61 million, giving a free cash flow of 1.05 billion.

Operating Cash Flow	1.48B
Capital Expenditures	-427.61M
Free Cash Flow	1.05B
FCF Per Share	2.10

Margins

Gross margin is 3.41%, with operating and profit margins of -17.25% and -35.14%.

Gross Margin	3.41%
Operating Margin	-17.25%
Pretax Margin	-37.02%
Profit Margin	-35.14%
EBITDA Margin	10.70%
EBIT Margin	-17.25%
FCF Margin	46.91%

Dividends & Yields

IST:BIOEN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-7.87%
FCF Yield	10.50%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 24, 2021. It was a forward split with a ratio of 3.3333333.

Last Split Date	Nov 24, 2021
Split Type	Forward
Split Ratio	3.3333333

Scores

Altman Z-Score	n/a
Piotroski F-Score	3